Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

OBJECTIVE: To evaluate the safety and efficacy of recombinant gamma interferon (rIFN gamma) in the treatment of patients with systemic sclerosis. METHODS: Sixteen patients with systemic sclerosis were treated with r-IFN gamma, 60 micrograms m-2 (low dose, n = 10) and 150 micrograms m-2 (high dose, n...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Vlachoyiannopoulos, P G, Tsifetaki, N, Dimitriou, I, Galaris, D, Papiris, S A, Moutsopoulos, H M
Формат: Artigo
Язык:Inglês
Опубликовано: 1996
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1010296/
https://ncbi.nlm.nih.gov/pubmed/8984943
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы